Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?
Omura
George A
GA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery*
D009944:Organoplatinum Compounds